Show simple item record

dc.contributor.authorMcNamara, Mairead Gen
dc.contributor.authorTimmins, H.en
dc.contributor.authorOsborne, A.en
dc.contributor.authorCox, R.en
dc.contributor.authorWasan, H. S.en
dc.contributor.authorCorrie, P.en
dc.contributor.authorGillmore, R.en
dc.contributor.authorSivakumar, S.en
dc.contributor.authorMa, Y. T.en
dc.contributor.authorFaluyi, O. O.en
dc.contributor.authorArora, A.en
dc.contributor.authorArif, S.en
dc.contributor.authorCanham, J.en
dc.contributor.authorHurt, C.en
dc.contributor.authorHubner, Richard Aen
dc.contributor.authorBridgewater, J. A.en
dc.contributor.authorAdams, R.en
dc.contributor.authorValle, Juan Wen
dc.date.accessioned2023-10-25T08:48:40Z
dc.date.available2023-10-25T08:48:40Z
dc.date.issued2023en
dc.identifier.citationMcNamara MG, Timmins H, Osborne A, Cox R, Wasan HS, Corrie P, et al. ABC-12: Exploring the microbiome in patients (pts) with advanced biliary tract cancer (BTC) in a first-line study of durvalumab in combination with cisplatin/gemcitabine (cis/ gem). Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772005635.en
dc.identifier.doi10.1200/JCO.2023.41.16_suppl.TPS4183en
dc.identifier.urihttp://hdl.handle.net/10541/626670
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1200/JCO.2023.41.16_suppl.TPS4183en
dc.titleABC-12: Exploring the microbiome in patients (pts) with advanced biliary tract cancer (BTC) in a first-line study of durvalumab in combination with cisplatin/gemcitabine (cis/ gem)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Manchester/The Christie NHS Foundation Trust, Manchester,en
dc.identifier.journalJournal of Clinical Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record